Shire Pharmaceuticals (Nasdaq: SHPGY), a specialty pharmaceutical company, is recently up $2.42 to $58.97 as Genzyme (Nasdaq: GENZ) sells ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE